Not to Miss: Intronic Variants, Treatment, and Review of the Phenotypic Spectrum in VPS13D -Related Disorder.
Martje G PaulyNorbert BrüggemannStephanie EfthymiouAnne GrözingerSokhna Haissatou DiawViorica ChelbanValentina TurchettiBarbara VonaVera TadicHenry HouldenAlexander MünchauKatja LohmannPublished in: International journal of molecular sciences (2023)
VPS13D is one of four human homologs of the vacuolar sorting protein 13 gene ( VPS13 ). Biallelic pathogenic variants in the gene are associated with spastic ataxia or spastic paraplegia. Here, we report two patients with intronic pathogenic variants: one patient with early onset severe spastic ataxia and debilitating tremor, which is compound-heterozygous for a canonical (NM_018156.4: c.2237-1G > A) and a non-canonical (NM_018156.4: c.941+3G>A) splice site variant. The second patient carries the same non-canonical splice site variant in the homozygous state and is affected by late-onset spastic paraplegia. We confirmed altered splicing as a result of the intronic variants and demonstrated disturbed mitochondrial integrity. Notably, tremor in the first patient improved significantly by bilateral deep brain stimulation (DBS) in the ventralis intermedius (VIM) nucleus of the thalamus. We also conducted a literature review and summarized the phenotypical spectrum of reported VPS13D -related disorders. Our study underscores that looking for mutations outside the canonical splice sites is important not to miss a genetic diagnosis, especially in disorders with a highly heterogeneous presentation without specific red flags.
Keyphrases
- early onset
- deep brain stimulation
- late onset
- copy number
- case report
- parkinson disease
- cerebral palsy
- obsessive compulsive disorder
- genome wide
- botulinum toxin
- upper limb
- endothelial cells
- photodynamic therapy
- dna methylation
- oxidative stress
- transcription factor
- small molecule
- protein protein
- replacement therapy
- genome wide identification
- genome wide analysis